Zu "850879-09-3" wurden 3 Artikel gefunden!

Für die Filterung wurden keine Ergebnisse gefunden!
Amuvatinib
Amuvatinib

Artikelnummer: SYN-1056-M001

Soluble in DMSO or ethanol. Amuvatinib is a potent, novel and orally active multi-targeted tyrosine kinase inhibitor, which inhibits a number of validated tumor targets including c-kit, PDGFRalpha and flt3, with IC(50) values of 10nM, 40nM and 81nM respectively. Target: PDGFR , Kinase Group: RTK , Substrate: Tyrosine
Schlagworte: MP-470
Anwendung: c-KIT / PDGFR inhibitor
CAS 850879-09-3
MW: 447,5 D
ab 154,00 €
Bewerten
Amuvatinib
Amuvatinib

Artikelnummer: Cay21461-1

Amuvatinib is a multi-targeted inhibitor of receptor tyrosine kinases that inhibits c-Kit, platelet-derived growth factor receptor alpha (PDGFRalpha), and c-Met (IC50s = 10, 40, and 81 nM, respectively). It inhibits growth and induces apoptosis in prostate cancer cell lines, with additive effects achieved when...
Schlagworte: HPK56, MP470, N-(1,3-benzodioxol-5-ylmethyl)-4-benzofuro[3,2-d]pyrimidin-4-yl-1-piperazinecarbothioamide
Anwendung: KIT receptor tyrosine kinase inhibitor
CAS 850879-09-3
MW: 447.5 D
ab 150,00 €
Bewerten
Amuvatinib
Amuvatinib

Artikelnummer: TGM-T2516-100mg

Description: Amuvatinib (MP470) is an orally bioavailable synthetic carbothioamide with potential antineoplastic activity. Target: c-Kit, Apoptosis, c-RET, c-Met/HGFR, FLT, DNA/RNA Synthesis, PDGFR. Smiles: C(NCC=1C=C2C(=CC1)OCO2)(=S)N3CCN(C4=C5C(C=6C(O5)=CC=CC6)=NC=N4)CC3. References: Hurley LH, et al. World...
Schlagworte: MP470, HPK 56
CAS 850879-09-3
MW: 447.51 D
ab 45,00 €
Bewerten